Presentation on February 10, 2016 at 10:45 AM Eastern Time
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that the
company will present at the Source Capital 2016 Disruptive Growth &
Healthcare Conference at 10:45 AM Eastern Time (7:45 AM Pacific Time) on
Wednesday, February 10, 2016. The presentation will take place in the
Tribeca Hub room at the Convene in New York City. For more information
on the conference or for investors to register, please go to www.SourceCapitalConference.com.
Dr. Marc Hedrick, CEO and President of Cytori Therapeutics, will provide
an update on current corporate activities and recent developments,
including progress on the STAR trial, the U.S. phase III trial focused
on Scleroderma related hand dysfunction, and other pipeline programs.
A live audio and video webcast of the presentation will be available
under the investor relations section of Cytori’s website at www.cytori.com
(http://ir.cytori.com).
A replay of the presentation will be available for 90 days following the
event. Please connect to Cytori’s website several minutes prior to the
start of the webcast to ensure adequate time for any software download
that may be necessary.
About Cytori Therapeutics
Cytori Therapeutics is a late stage cell therapy company developing
autologous cell therapies from adipose tissue to treat a variety of
medical conditions. Data from preclinical studies and clinical trials
suggest that Cytori Cell Therapy™ acts principally by improving blood
flow, modulating the immune system, and facilitating wound repair. As a
result, Cytori Cell Therapy™ may provide benefits across multiple
disease states and can be made available to the physician and patient at
the point-of-care through Cytori’s proprietary technologies and
products. For more information: visit www.cytori.com.
About Source Capital Group
Source Capital Group, Inc. was founded in 1992 on the belief that the
best investment advice should be independent, unbiased and tailor-made
for the individual client’s needs. Source Capital began as a boutique
investment banking firm specializing in small to medium sized
transactions. We have grown to include businesses in general securities,
emerging market securities, distressed and high yield debt securities,
in addition to our investment banking activity. http://www.sourcegrp.com/
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements that involve
known and unknown risks and uncertainties. All statements, other than
historical facts are forward-looking statements. Such statements are
subject to risks and uncertainties that could cause our actual results
and financial position to differ materially. These risks and
uncertainties are described under the "Risk Factors" in Cytori's
Securities and Exchange Commission Filings, included in our annual and
quarterly reports.
There may be events in the future that we are unable to predict, or over
which we have no control, and our business, financial condition, results
of operations and prospects may change in the future. We assume no
responsibility to update or revise any forward-looking statements to
reflect events, trends or circumstances after the date they are made
unless we have an obligation under U.S. Federal securities laws to do so.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160204006231/en/
Copyright Business Wire 2016